Insider · CIK 0001976855
Marcelo Rabach
Files at ARCO (Arcos Dorados Holdings Inc.). First filing -, latest -.
In brief
Marcelo Rabach files SEC Form 4 as director at ARCO (Arcos Dorados Holdings Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Marcelo Rabach has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 17, 2025 | ARCO Arcos Dorados Holdings Inc. | 100,000 0.08% of outstanding | $834k | Mar 17, 2025 | none |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 10, 2026 | ARCO Arcos Dorados Holdings Inc. | AGrant or award Phantom Restricted Stock Unitderivative | +4,435 | - | - | 4,435 | May 12, 2026 |
Questions about Marcelo Rabach
Answered from the filings on this page, as of the latest one.
Is Marcelo Rabach buying or selling?
Marcelo Rabach has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Marcelo Rabach's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Marcelo Rabach has 0.
Where does Marcelo Rabach file Form 4?
Marcelo Rabach has filed Form 4 at ARCO (Arcos Dorados Holdings Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.